A roller-coaster ride: Introduction of pentavalent vaccine in India

A roller-coaster ride: Introduction of pentavalent vaccine in India

Petitioners in High Court cite low disease burden due to Hib and safety concerns as main reasons for opposing the introduction of the vaccine.

Bibliographic Details
Main Authors:	Harish Nair, Indrajit Hazarika, Ashok Patwari
Format:	Article
Language:	English
Published:	Edinburgh University Global Health Society 2011-06-01
Series:	Journal of Global Health
Subjects:	Pentavalent vaccine India
Online Access:	http://www.jogh.org/documents/issue201101/6-Viewpoint%20Nair.pdf

Similar Items

An infant who suffered seizures many times after pentavalent vaccination: A case report
by: Meryem Erat Nergiz, et al.
Published: (2020-05-01)

The Implementation of Pentavalent Vaccine DTaP/IPV/Hib within National Immunization Schedule
by: Irina V. Mikheeva, et al.
Published: (2019-09-01)

Deaths reported after pentavalent vaccine compared with death reported after diphtheria-tetanus-pertussis vaccine: An exploratory analysis
by: Jacob Puliyel, et al.
Published: (2018-01-01)

MODELING TOWARDS PENTAVALENT VACCINE COVERAGE IN PAKISTAN
by: Muhammad Imran, et al.
Published: (2016-03-01)

Estimation of the wastage rate of MMR and pentavalent vaccines in open and closed vials in three western provinces of Iran
by: Seyed Mohsen Zahraei, et al.
Published: (2020-05-01)

Meta-analysis of the effectiveness of pentavalent live oral vaccine for the prevention of severe forms of rotavirus gastroenteritis in children
by: A. A. Kosova, et al.
Published: (2020-11-01)

Study of Serologic Response Rate to Pertussis after Administration of the Third Dose of Pentavalent Vaccine in Children 12 Months Old in Karaj City, Iran
by: Reza Arjmand, et al.
Published: (2018-02-01)

Comparison of complications of pentavalent and DTP vaccination in infants aged 2-6 months in Anzali, Iran
by: Reza Sharafi, et al.
Published: (2016-06-01)

Reactogenicity, safety and immunological efficacy of the live, pentavalent rotavirus vaccine in childhood immunization (results of the multicenter clinical trial)
by: Irina V. Feldblium, et al.
Published: (2020-09-01)

Immune Response of Indian Preterm Infants to Pentavalent Vaccine Varies With Component Antigens and Gestational Age
by: Archana Kulkarni-Munje, et al.
Published: (2021-04-01)

Immunogenicity and Complications of the Pentavalent Vaccine in Iranian Children
by: Mina Ekrami Noghabi, et al.
Published: (2021-10-01)

PHARMACOECONOMIC ANALYSIS OF USE OF PENTAVALENT COMBINATION VACCINE WITH ACELLULAR PERTUSSIS COMPONENT IN THE FRAMEWORK OF THE REGIONAL IMMUNIZATION SCHEDULE OF KRASNODAR FOR ALL CHILDREN AGED 0–18 MONTHS AND SEPARATLY FOR CHILDREN AT RISK
by: A. Yu. Kulikov, et al.
Published: (2014-11-01)

The Analysis of Factors that Related to Advanced Pentavalent Immunization Status in Sinjai Regency
by: Indra Dwinata, et al.
Published: (2019-04-01)

Pentavalent Antimonials: New Perspectives for Old Drugs
by: Raul R. Ribeiro, et al.
Published: (2009-06-01)

Pentavalent vaccination in Kenya: coverage and geographical accessibility to health facilities using data from a community demographic and health surveillance system in Kilifi County
by: Agoi, F., et al.
Published: (2022)

Vaccine Wastage Assessment After Introduction of Open Vial Policy in Surat Municipal Corporation Area of India
by: Prakash B. Patel, et al.
Published: (2016-04-01)

VACCINATION AGAINST ROTAVIRUS INFECTION AS A CONTRIBUTION TO CHILDREN'S HEALTH
by: A. G. Yuzhakova, et al.
Published: (2017-12-01)

Vaccine prevention of rotavirus infection: Social significance and effectiveness
by: A. G. Yuzhakova, et al.
Published: (2017-06-01)

The Effect of Aromatherapy by Lavender Oil on Infant Vaccination Pain: a Double Blind Randomized Controlled Trial
by: Farideh Vaziri, et al.
Published: (2019-03-01)

Effectiveness of Chitosan Nanoparticles in Development of Pentavalent Clostridial Toxoid Vaccine in Terms of Clinical Pathology Elements and Immunological Responses
by: M. Fathi Najafi, et al.
Published: (2020-09-01)

Rotavirus Infection in Children is an Unsolved Problem. Review of Guidelines for Vaccinal Prevention
by: Alexandr A. Baranov, et al.
Published: (2017-10-01)

COMBINED VACCINE IS AN EFFECTIVE AND SAFE PROTECTION FROM FIVE CONTROLLABLE INFECTIONS
by: D. A. Novikova, et al.
Published: (2014-05-01)

Mixed Antimony(V) Complexes with Different Sugars to Modulate the Oral Bioavailability of Pentavalent Antimonial Drugs
by: Weverson A. Ferreira, et al.
Published: (2014-04-01)

Hepatitis B Vaccination in Senegalese Children: Coverage, Timeliness, and Sociodemographic Determinants of Non-Adherence to Immunisation Schedules (ANRS 12356 AmBASS Survey)
by: Lauren Périères, et al.
Published: (2021-05-01)

Pentavalent antimonial nephrotoxicity in the rat Disfunção tubular renal em ratos tratados com antimoniais pentavalentes
by: Joel Paulo R. Veiga, et al.
Published: (1990-08-01)

Comparative Assessment of Preventable Socioeconomic Damage in Different Approaches to the Prevention of Vaccine-Controlled Infections in the Framework of the National Vaccination Schedule
by: N. I. Briko, et al.
Published: (2020-03-01)

A Pilot Randomized Clinical Trial: Oral Miltefosine and Pentavalent Antimonials Associated With Pentoxifylline for the Treatment of American Tegumentary Leishmaniasis
by: Sofia Sales Martins, et al.
Published: (2021-07-01)

Riding a roller coaster: narrative typologies of patients with neuroendocrine tumors
by: Miconi A, et al.
Published: (2015-12-01)

COVID-19 Pandemic: A Speed Breaker for Routine Immunisation
by: Sumit Singh Bhadoria, et al.
Published: (2021-04-01)

Virtual Roller Coaster
by: Zhao, Yu-Sen, et al.
Published: (1998)

A retrospective cohort study of the effectiveness and adverse events of intralesional pentavalent antimonials in the treatment of cutaneous leishmaniasis
by: Bruna Côrtes Rodrigues, et al.
Published: (2020-12-01)

The Results of the Mass Immunization Program against Rotavirus Infection of Children of the First year of Life in a Separate Territory of the Moscow Region
by: L. V. Feklisova, et al.
Published: (2019-09-01)

Nueva metodología para la formulación de la vacuna Heberpenta-L
by: Imeray Díaz, et al.
Published: (2014-01-01)

Fairground Rides and Roller Coasters: Measurement and Control in Context for Today's School Children
by: Barbara Higginbotham FRSA
Published: (2010-02-01)

Impact of the introduction of new vaccines and vaccine wastage rate on the cost-effectiveness of routine EPI: lessons from a descriptive study in a Cameroonian health district
by: Levy Pierre, et al.
Published: (2011-05-01)

Epidemiological Profile of Meningitis following Pentavalent Vaccination in Iran: Impact of Vaccine Introduction
by: Saber Heidari, et al.
Published: (2021-04-01)

Design Analysis of Roller Coasters
by: Hunt, Kristen
Published: (2018)

Carotid artery dissection plus subdural hematoma after a roller-coaster ride
by: Ana Luíza Vieira de Araújo, et al.
Published: (2014-12-01)

A brief history of vaccines & vaccination in India
by: Chandrakant Lahariya
Published: (2014-01-01)

Higher valent Pneumococcal Conjugate Vaccines: is it a roller coaster?
by: Godwin Oligbu
Published: (2020-01-01)